Skin Cancer Drug, Ipilimumab News Boosts Bristol-Myers Squibb Company Shares

Published: Jun 07, 2010

Reuters -- Bristol-Myers Squibb Co's shares rose more than 5 percent on Monday after news over the weekend that its experimental drug ipilimumab extended survival in patients with deadly skin cancer.

Back to news